Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesse Mckenney

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
American Journal of Clinical Pathology|May 12, 2026
Diagnostic sensitivity and specificity of INSM1 in pheochromocytomas versus adrenal cortical lesionsDouglas Jian-Xian Wu, Anandi Lobo, Jesse McKenney, et al.
Pathology, Research and Practice|February 21, 2025
Incidental early mixed epithelial and stromal tumor of the efferent testicular-ductular system of the genitourinary tract: A small case series with literature reviewElaina Daniels, Jesse McKenney, Hikmat Al-Ahmadie, et al.
Urology|November 23, 2020
PTEN Hamartoma Tumor Syndrome: A Case of Renal Cell Carcinoma in a Young FemaleRathika R Ramkumar, Prithvi B Murthy, Jane K Nguyen, et al.
The American Journal of Surgical Pathology|September 13, 2013
The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parametersBrett Delahunt, John C Cheville, Guido Martignoni, et al.
Cell Reports|September 11, 2025
Disrupting the interaction between androgen receptor and its coregulator WDR77 delays the growth of treatment-resistant prostate cancerUjjwal R Dahiya, Sangeeta Kumari, Nidhi Singh, et al.
Urologic Oncology|June 16, 2024
Impact of pathologic re-review on grade, clinical stage, and risk stratification for patients with nonmuscle invasive bladder cancerRebecca A Campbell, Andrew Wood, Patrick D Michael, et al.
Clinical Genitourinary Cancer|March 20, 2018
Prognostic Factors and Risk Stratification in Invasive Upper Tract Urothelial CarcinomaHamid Emamekhoo, Puneet Dhillon, Dharmesh Gopalakrishnan, et al.
Urology|January 17, 2025
Low Baseline IsoPSA Index is Associated With a Prolonged Low Risk of Clinically Significant Prostate Cancer Diagnosis in Men With an Elevated PSANour Abdallah, Rebecca A Campbell, Tarik Benidir, et al.
European Urology Focus|May 4, 2021
Computationally Derived Cribriform Area Index from Prostate Cancer Hematoxylin and Eosin Images Is Associated with Biochemical Recurrence Following Radical Prostatectomy and Is Most Prognostic in Gleason Grade Group 2Patrick Leo, Sacheth Chandramouli, Xavier Farré, et al.
The American Journal of Surgical Pathology|November 23, 2023
Hybrid Oncocytic Tumors (HOTs) in Birt-Hogg-Dubé Syndrome Patients-A Tale of Two Cities: Sequencing Analysis Reveals Dual Lineage Markers Capturing the 2 Cellular Populations of HOTXiao-Ming Wang, Rahul Mannan, Yuping Zhang, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
American Journal of Clinical Pathology|May 12, 2026
Diagnostic sensitivity and specificity of INSM1 in pheochromocytomas versus adrenal cortical lesionsDouglas Jian-Xian Wu, Anandi Lobo, Jesse McKenney, et al.
Pathology, Research and Practice|February 21, 2025
Incidental early mixed epithelial and stromal tumor of the efferent testicular-ductular system of the genitourinary tract: A small case series with literature reviewElaina Daniels, Jesse McKenney, Hikmat Al-Ahmadie, et al.
Urology|November 23, 2020
PTEN Hamartoma Tumor Syndrome: A Case of Renal Cell Carcinoma in a Young FemaleRathika R Ramkumar, Prithvi B Murthy, Jane K Nguyen, et al.
The American Journal of Surgical Pathology|September 13, 2013
The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parametersBrett Delahunt, John C Cheville, Guido Martignoni, et al.
Cell Reports|September 11, 2025
Disrupting the interaction between androgen receptor and its coregulator WDR77 delays the growth of treatment-resistant prostate cancerUjjwal R Dahiya, Sangeeta Kumari, Nidhi Singh, et al.
Urologic Oncology|June 16, 2024
Impact of pathologic re-review on grade, clinical stage, and risk stratification for patients with nonmuscle invasive bladder cancerRebecca A Campbell, Andrew Wood, Patrick D Michael, et al.
Clinical Genitourinary Cancer|March 20, 2018
Prognostic Factors and Risk Stratification in Invasive Upper Tract Urothelial CarcinomaHamid Emamekhoo, Puneet Dhillon, Dharmesh Gopalakrishnan, et al.
Urology|January 17, 2025
Low Baseline IsoPSA Index is Associated With a Prolonged Low Risk of Clinically Significant Prostate Cancer Diagnosis in Men With an Elevated PSANour Abdallah, Rebecca A Campbell, Tarik Benidir, et al.
European Urology Focus|May 4, 2021
Computationally Derived Cribriform Area Index from Prostate Cancer Hematoxylin and Eosin Images Is Associated with Biochemical Recurrence Following Radical Prostatectomy and Is Most Prognostic in Gleason Grade Group 2Patrick Leo, Sacheth Chandramouli, Xavier Farré, et al.
The American Journal of Surgical Pathology|November 23, 2023
Hybrid Oncocytic Tumors (HOTs) in Birt-Hogg-Dubé Syndrome Patients-A Tale of Two Cities: Sequencing Analysis Reveals Dual Lineage Markers Capturing the 2 Cellular Populations of HOTXiao-Ming Wang, Rahul Mannan, Yuping Zhang, et al.
Pageof 2